Blockchain in Clinical Trials - How and Why Blockchain and Distributed Ledger Technologies (DLTs) are new disruptive approaches in the Clinical Trials Industry? A pragmatic seminar with views from Blockchain , Pharma and CRO industries professionals
We are in the midst of a significant shift in pharmaceutical drug development, with the inception of new paradigms and technologies. Blockchain has arrived to fundamentally create a new paradigm patient-centric drug development and healthcare best practice.
For the last 2 years, multiple initiatives are moving the Blockchain for Clinical Trials Conversation from Why to How & When with Industry, Regulatory and the Patient .
This seminar will embrace several views from pharmaceutical professionals, technologists, clinical trial service providers and other stakeholders who are evaluating the viable use cases for Blockchain /distributed ledger technologies (DLTs).
14:00 -14:30: Welcome
14:30 -17:30: Workshop
Introduction of the Workshop Objectives and Speakers - by Olivier Simon
« Introduction to the Block Chain : Introduction to the Blockchain and Distributed Ledger Technologies (DLTs) » by Christophe Van Huffel – PhD (GENERGON)
« Why is Blockchain a new paradigm in the Pharma and in Clinical Trials industry? » by Ingrid Van Rompaey- PhD (VISO Clinical)
« Industries initiatives in the application of Blockchain for Clinical Trials - IEEE (Standard Association): initiatives / tools » by Maria Palombini (IEEE)
« Applications of Patient-driven healthcare Blockchain networks in Clinical Trials – How and Why this will disrupt the current approaches of the Pharma R&D and Healthcare industries ? ” by Dr Robert Chu – (Embleema)
17:30 - 18h00: Wrap up
18h00 - 20h00: Cocktail Networking